FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and pharmaceutical industry, namely to pharmaceutical compositions with prolonged action, used for correction of psychosomatic disorders. As active component, composition contains alimemazine tartrate, as well as target auxiliary substances: lactose, hydroxypropylmethylcellulose, pre-gelled starch, magnesium stearate, colloidal silicon dioxide with the specified component ratio. Composition is made in form of tablets, covered with coating, which consists of polyvinyl alcohol, talc, polyethylene glycol, titanium dioxide, acceptable dyes.
EFFECT: pharmaceutical composition extends arsenal of medications and has storage term 2 years.
5 cl, 6 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR CORRECTION OF PSYCHOSOMATIC MANIFESTATIONS | 2009 |
|
RU2384336C1 |
| PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION | 2009 |
|
RU2414903C1 |
| METHOD OF OBTAINING ALIMEMAZINE TARTRATE SOLUTION FOR INTRODUCTION BY INJECTION | 2013 |
|
RU2537136C1 |
| METHOD FOR PRODUCTION OF CLOZAPINE PHARMACEUTICAL COMPOSITION IN FORM OF TABLETS AND PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2441651C1 |
| RETARD TABLETS OF TRIMEBUTINE | 2013 |
|
RU2536254C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF HARD PERORAL DRUG FOR TREATMENT OF GASTROINTESTINAL TRACT DISEASES | 2009 |
|
RU2418576C2 |
| SUSTAINED RELEASE CILOSTASOL DOSAGE FORM | 2018 |
|
RU2686066C1 |
| AGENT FOR TREATING FUNCTIONAL GASTROINTESTINAL DISEASES | 2020 |
|
RU2740750C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ALIMAMAZINE TARTRATE | 2017 |
|
RU2659200C1 |
| DRUG PREPARATION IN FORM OF ORALLY DISPERSIBLE TABLET AND METHOD FOR MAKING DRUG PREPARATION | 2012 |
|
RU2503447C1 |
